Matches in SemOpenAlex for { <https://semopenalex.org/work/W2323875696> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2323875696 endingPage "A186" @default.
- W2323875696 startingPage "A186" @default.
- W2323875696 abstract "<h3>Introduction</h3> Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD). Strategies to increase donor organ availability and to prolong the transplanted kidney9s survival have become priorities in kidney transplantation. Standard immunosuppressive therapy consists of initial treatment and maintenance regimes to prevent rejection and short courses of more intensive immunosuppressive therapy to treat episodes of acute rejection. Immunosuppressive drugs may cause electrocardiographic changes as increased QT interval (QTc) which is associated with a variety of cardiac diseases and sudden death. The aim of our study is to compare the effect of two different calcineurin inhibitors (cyclosporine A and tacrolimus), azatiopirin and everolimus on QT interval in renal transplant patients. <h3>Method</h3> A total of 98 patients were assigned into the study (51 Tacrolimus, 23 cyclosporine A, 15 everolimus and 9 azatiopirin). The mean time after transplantation was 18 months. QT dispersion was calculated according to Bazzet9s formula from the 12 leads electrocardiography. The corrected QT (QTc) values from pretransplant ECGs and the follow-up ECGs (at least 6 months) were compared. <h3>Results</h3> There were no significant differences between groups with respect to pretransplantation QT times (p≥0.05). QT times were increased after transplantation for all patient groups. Patients receiving cyclosporine A, azatiopirin and everolimus had statistically significantly increased QTc times than patients on tacrolimus (p=0.042). <h3>Discussion</h3> We showed that QT interval was affected by all immunosuppressive drugs. However, QTc interval prolongation was less prominent in patients on tacrolimus in comparison to other drugs. QTc prolongation is an independent predictor of mortality in patients with ESRD who are candidates for renal transplantation. We revealed that tacrolimus is the safest drug with respect to QT prolongation in renal transplant patients. Tacrolimus should be considered as a drug of choice in patients developing QT prolongation during the course of immunosuppressive treatment." @default.
- W2323875696 created "2016-06-24" @default.
- W2323875696 creator A5013481330 @default.
- W2323875696 creator A5019515704 @default.
- W2323875696 creator A5032073636 @default.
- W2323875696 creator A5048541226 @default.
- W2323875696 creator A5076942763 @default.
- W2323875696 creator A5083956771 @default.
- W2323875696 date "2011-10-01" @default.
- W2323875696 modified "2023-10-01" @default.
- W2323875696 title "Impact of different immunosuppressive drugs on QT interval in renal transplant patients" @default.
- W2323875696 doi "https://doi.org/10.1136/heartjnl-2011-300867.545" @default.
- W2323875696 hasPublicationYear "2011" @default.
- W2323875696 type Work @default.
- W2323875696 sameAs 2323875696 @default.
- W2323875696 citedByCount "0" @default.
- W2323875696 crossrefType "journal-article" @default.
- W2323875696 hasAuthorship W2323875696A5013481330 @default.
- W2323875696 hasAuthorship W2323875696A5019515704 @default.
- W2323875696 hasAuthorship W2323875696A5032073636 @default.
- W2323875696 hasAuthorship W2323875696A5048541226 @default.
- W2323875696 hasAuthorship W2323875696A5076942763 @default.
- W2323875696 hasAuthorship W2323875696A5083956771 @default.
- W2323875696 hasBestOaLocation W23238756961 @default.
- W2323875696 hasConcept C118441451 @default.
- W2323875696 hasConcept C126322002 @default.
- W2323875696 hasConcept C128057223 @default.
- W2323875696 hasConcept C164705383 @default.
- W2323875696 hasConcept C2778653478 @default.
- W2323875696 hasConcept C2778849806 @default.
- W2323875696 hasConcept C2779699572 @default.
- W2323875696 hasConcept C2780303639 @default.
- W2323875696 hasConcept C2909675724 @default.
- W2323875696 hasConcept C2911091166 @default.
- W2323875696 hasConcept C71924100 @default.
- W2323875696 hasConceptScore W2323875696C118441451 @default.
- W2323875696 hasConceptScore W2323875696C126322002 @default.
- W2323875696 hasConceptScore W2323875696C128057223 @default.
- W2323875696 hasConceptScore W2323875696C164705383 @default.
- W2323875696 hasConceptScore W2323875696C2778653478 @default.
- W2323875696 hasConceptScore W2323875696C2778849806 @default.
- W2323875696 hasConceptScore W2323875696C2779699572 @default.
- W2323875696 hasConceptScore W2323875696C2780303639 @default.
- W2323875696 hasConceptScore W2323875696C2909675724 @default.
- W2323875696 hasConceptScore W2323875696C2911091166 @default.
- W2323875696 hasConceptScore W2323875696C71924100 @default.
- W2323875696 hasIssue "Suppl 3" @default.
- W2323875696 hasLocation W23238756961 @default.
- W2323875696 hasOpenAccess W2323875696 @default.
- W2323875696 hasPrimaryLocation W23238756961 @default.
- W2323875696 hasRelatedWork W2087821141 @default.
- W2323875696 hasRelatedWork W2323875696 @default.
- W2323875696 hasRelatedWork W2332638576 @default.
- W2323875696 hasRelatedWork W2334466292 @default.
- W2323875696 hasRelatedWork W2400889191 @default.
- W2323875696 hasRelatedWork W2560501611 @default.
- W2323875696 hasRelatedWork W2797773997 @default.
- W2323875696 hasRelatedWork W3033723151 @default.
- W2323875696 hasRelatedWork W3146940434 @default.
- W2323875696 hasRelatedWork W4240284178 @default.
- W2323875696 hasVolume "97" @default.
- W2323875696 isParatext "false" @default.
- W2323875696 isRetracted "false" @default.
- W2323875696 magId "2323875696" @default.
- W2323875696 workType "article" @default.